Enwei Pharmaceutical (301331.SZ) plans to contribute 20 million yuan to invest in Jiaxing Panlin Jiayi Entrepreneurship Investment Partnership Enterprise.

Zhimedia Finance APP News, Enwei Medicine (301331.SZ) announced that recently, the company and Shanghai Panlin Hongyu Enterprise Management Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Panlin Hongyu"), Tangshan Jinkun Chemical Co., Ltd., Li Jiaojiao and others jointly signed the "Jiaxing Panlin Jiayi Entrepreneurship Investment Partnership Enterprise (Limited Partnership) Partnership Agreement" (hereinafter referred to as "Partnership Agreement"). According to the agreement, the company, as a limited partner, will invest RMB 20 million of its own funds to subscribe for investment fund shares, accounting for 9.9502% of the investment.